Table 5.
Plasma and liver arylesterase (AE) activity and VLDL and liver oxidation of animals fed the experimental diets.
| ANOVA | ||||
|---|---|---|---|---|
| ED | D | DE | p | |
| Plasma AE (U/L) * | 237 ± 43.06 b | 163 ± 29.56 a | 368 ± 58.59 c | p < 0.001 |
| Plasma AE:cholesterol (U/mg) ** | 0.29 ± 0.05 b | 0.15 ± 0.02 a | 0.39 ± 0.05 c | p < 0.001 |
| Liver AE (U/g protein) | 7.70 ± 0.97 b | 5.36 ± 0.83 a | 10.93 ± 3.28 b | p < 0.001 |
| VLDL-ox (TBARS, mg MDA/L) | 2.31 ± 0.29 ab | 2.58 ± 0.16 b | 2.22 ± 0.23 a | p = 0.024 |
| Liver-ox (TBARS, mg MDA/mg protein) | 2.63 ± 0.58 a | 3.63 ± 0.25 b | 2.49 ± 0.33 a | p < 0.001 |
Results are means ± SD (n = 8). Labeled means in a row without a common letter differ (p < 0.05; a < b < c; ab = a or b; ANOVA followed by the Bonferroni or T2 Tamhane post hoc test). ED: rats fed the CFE-diet since the beginning of the study; D: rats fed the Chol-diet; DE: rats fed the CFE-diet when the diabetic state was confirmed. For more abbreviations see footnotes of Table 1. * One unit of AE was defined as mmols of phenol formed from phenylacetate per minute; ** Units AE (U/L)/total cholesterol (mg/L).